Herbs (Global Traditional) · Ayurveda
Yavasa (Alhagi pseudalhagi) (Alhagi pseudalhagi)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Yavasa (Alhagi pseudalhagi) is an Ayurvedic herb containing flavonoids and alkaloids that may support respiratory and urinary health. The plant's bioactive compounds potentially work through anti-inflammatory and diuretic mechanisms.
Yavasa (Alhagi pseudalhagi) is a thorny perennial shrub native to arid regions of Asia, the Middle East, and North Africa, belonging to the Fabaceae family. The roots, leaves, flowers, and whole plant are harvested and processed into various traditional preparations including powders, decoctions, infusions, juices, and oils.
No human clinical trials, RCTs, or meta-analyses specific to Yavasa were identified in the available research. Limited evidence exists only from in vitro and animal studies suggesting anti-inflammatory and analgesic effects, but human clinical data is completely absent.
Traditional Ayurvedic dosages include: 20-30 ml hot root infusion 2-3 times daily; 5 g fine root powder with honey 1-2 times daily; cold root infusion with sugar candy for specific conditions. No clinically studied dosage ranges are available due to absence of human trials. Consult a healthcare provider before starting any new supplement.
Yavasa (Alhagi pseudalhagi) is not consumed as a conventional food, so standard macronutrient profiling (calories, carbohydrates, protein, fat per serving) is limited. Its significance lies in its phytochemical and bioactive compound content, primarily studied from aerial parts, roots, and exudates (manna). Key constituents include: **Flavonoids & Phenolics:** Isorhamnetin, isorhamnetin-3-O-glucoside, kaempferol, quercetin, and myricetin glycosides (reported in concentrations ranging from ~0.5–3.0 mg/g dry weight depending on plant part and extraction method); these are the primary contributors to its antioxidant capacity. **Alkaloids:** Small amounts of β-phenethylamine derivatives and trace indole-type alkaloids have been identified. **Tannins:** Both condensed and hydrolysable tannins are present (~2–5% dry weight in aerial parts), contributing to astringent and anti-diarrheal properties. **Saponins:** Triterpene saponins have been reported, though precise concentrations vary significantly by geographic origin. **Fatty acids & Sterols:** β-Sitosterol, stigmasterol, and small quantities of unsaturated fatty acids (oleic, linoleic) are present in seed and aerial portions. **Coumarins:** Trace amounts including scopoletin have been documented. **Vitamins & Minerals:** The plant contains moderate amounts of vitamin C (~15–30 mg/100 g fresh weight in young shoots, traditionally eaten in some regions), along with minerals including potassium, calcium, magnesium, iron, and zinc (iron reported ~8–15 mg/100 g dry weight; calcium ~200–400 mg/100 g dry weight in aerial parts — values are approximate and vary with soil conditions). **Fiber:** Aerial parts are notably high in crude fiber (~25–35% dry weight), which underlies traditional use for constipation. **Manna exudate (Turanjabīn):** The sugary exudate is rich in simple sugars — primarily sucrose, glucose, and fructose (~60–75% by weight) — along with mucilaginous polysaccharides and small amounts of organic acids. **Bioavailability notes:** Flavonoid glycosides (e.g., isorhamnetin-3-O-glucoside) require intestinal enzymatic hydrolysis for absorption; oral bioavailability of free flavonoid aglycones is generally low (estimated <10%) due to rapid Phase II metabolism. Tannin content may further reduce bioavailability of co-consumed minerals (especially iron and zinc) through chelation. The manna's simple sugars are highly bioavailable. Most pharmacological data are derived from in vitro or animal models; human pharmacokinetic data for Yavasa-specific compounds are not available.
Yavasa contains flavonoids, alkaloids, and phenolic compounds that may exert anti-inflammatory effects by inhibiting cyclooxygenase and lipoxygenase pathways. The plant's diuretic properties are attributed to its potassium content and potential effects on renal sodium-potassium ATPase pumps. Respiratory benefits may involve bronchodilatory actions through beta-2 adrenergic receptor modulation.
No clinical trials have been conducted specifically on Yavasa (Alhagi pseudalhagi) for human health outcomes. Traditional Ayurvedic texts document its use for respiratory conditions like asthma and bronchitis, as well as kidney stone management. Preliminary phytochemical studies have identified bioactive compounds, but human efficacy and safety data are lacking. The evidence base relies entirely on traditional use rather than controlled clinical research.
Safety data for Yavasa is limited due to lack of clinical studies. Potential side effects may include gastrointestinal upset or allergic reactions in sensitive individuals. The herb's diuretic properties could potentially interact with blood pressure medications or diuretics. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with kidney disorders should consult healthcare providers before use.
